Introduction {#sec1}
============

*Myroides* species, previously named as *Flavobacterium odoratum*, are aerobic Gram-negative bacteria that can be found in environmental sources such as soil and water, but are not residents of the normal human microflora [@bib1]. The genus *Myroides* comprises two species, *Myroides odoratus* and *Myroides odoratimimus*[@bib2]. Taking into consideration their role as causative agents in human disease, both *M. odoratimimus* and *M. odoratus* are seen rarely as opportunistic pathogens, causing infections in severely immunocompromised patients and rarely, in immunocompetent hosts [@bib1; @bib3]. *Myroides odoratimimus* strains have been found to be responsible for urinary tract infections [@bib4; @bib5], cellulitis [@bib6; @bib7] in immunocompromised patients, and also for septic shock, pneumonia and soft-tissue infections [@bib1; @bib8] in immunocompetent hosts. In addition, three outbreaks of *M. odoratimimus*, two of urinary tract infections and the third of central venous catheter-associated bloodstream infections due to contaminated water, have been reported [@bib2; @bib4].

Antibiotic resistance patterns of *Myroides* strains show variable susceptibility to β-lactams [@bib5], with a conserved decreased susceptibility to cephalosporins and carbapenems [@bib9]. This decreased susceptibility is the result of the production of a chromosome-encoded β-lactamase MUS-1. This enzyme is a member of the subclass B1 of metallo-β-lactamases and is distantly related to other metalloenzymes, being most closely related to IND-1 from *Chryseobacterium indologenes* (42% amino acid identity). However, phylogenic analysis showed that MUS-1 belongs to the same phylogenic lineage of subclass B1 enzymes that groups the subclass B1 β-lactamases of *Flavobacterium* species [@bib9]. Here we report a novel variant, MUS-2, of the chromosome-encoded β-lactamase MUS-1 from *M. odoratimimus* isolated from livestock animals in Lebanon.

Materials and methods {#sec2}
=====================

Bacterial isolates {#sec2.1}
------------------

Three imipenem-resistant *M. odoratimimus* strains (32, 35a and 104b) were isolated from two livestock farms of cows and pigeons by rectal swabs (32: farm 1, cow; 35a: farm 1, pigeon; 104b: farm 2, cow) in January 2014. These strains were collected during a study that aimed to detect carbapenemase-encoding genes in animals in Lebanon [@bib10]. They were isolated on MacConkey agar supplemented by ertapenem (1 mg/L), from alive and non-sick animals without contact with any other animals. Strains were sub-cultured on trypticase soy agar plates at 37°C for 18--24 h and identification was confirmed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) (Microflex™; Bruker Daltonics, Bremen, Germany) with [FlexControl]{.smallcaps} software (Bruker Daltonics).

Antibiotic susceptibility testing {#sec2.2}
---------------------------------

Antibiotic susceptibility testing was determined on Müller--Hinton agar by standard disc diffusion method as recommended by the European Committee on Antimicrobial Susceptibility Testing (EUCAST; [www.eucast.org](http://www.eucast.org){#intref0015}). Seventeen antibiotics were tested, including ticarcillin, ticarcillin-clavulanic acid, piperacillin, piperacillin-tazobactam, ceftazidime, cefotaxime, cefepime, aztreonam, amikacin, tobramycin, gentamicin, ciprofloxacin, rifampicin, ertapenem, meropenem, imipenem and colistin (Bio-Rad, Marnes-la-Coquette, France). The MIC for imipenem was determined using the Etest method (bioMérieux, La Balmes les Grottes, France) and the result was interpreted according to the EUCAST breakpoint for *Enterobacteriaceae* (susceptible if MIC ≤ 2 mg/L)

Phenotypic and molecular detection of carbapenemases {#sec2.3}
----------------------------------------------------

Isolates were screened for carbapenemase production using the modified Hodge test, the EDTA, the Modified CarbaNP test as previously described [@bib11; @bib12; @bib13] and also by MALDI-TOF MS Ultraflex assay [@bib14]. Screening for class A, B and D carbapenemases was carried out using PCR according to previous protocols and previously described primers including for *bla*~VIM~, *bla*~IMP~, *bla*~NDM-1~, *bla*~KPC~ and all the *bla*~OXA~ variants [@bib15; @bib16; @bib17; @bib18; @bib19; @bib20]. In addition, amplification of the chromosomal MUS gene was performed using primers designed in this study (MUS-F/R 5′-CGTTAGGCACACCAGAAGAA-3\'/3′-TCCACACCATTCTGAGCGTA-5′). These primers were designed outside the region containing the *bla*~MUS-1~ located on the chromosome of a random *M. odoratimimus* genome deposited in GenBank. PCR products were purified and sequenced using the Big dye terminator chemistry on an ABI 3730 automated sequencer (Applied Biosystems, Foster City, CA, USA). The sequences obtained were analysed using [BlastN]{.smallcaps} and [BlastP]{.smallcaps} against the NCBI database ([www.ncbi.nlm.nih.gov](http://www.ncbi.nlm.nih.gov){#intref0020}).

Cloning of the MUS-2 gene {#sec2.4}
-------------------------

The full length of the *bla*~MUS-2~ from *M. odoratimimus* was amplified using *Herculase II Fusion Enzyme* with *dNTPs Combo (*Agilent Technologies, Santa Clara, CA, USA) with primer MUS_F/MUS_R. The gene was then cloned into the high-copy-number plasmid pCR-BluntII-TOPO using the Zero Blunt TOPO PCR cloning kit (Invitrogen, Calrsbad, CA, USA). The resulting plasmid pTOPO-*MUS-2* was transformed into TOP10 Electrocomp™ *Escherichia coli*. Transformants were selected on Luria--Bertani agar supplemented with 100 mg/L of kanamycin; the presence of the insert was confirmed by PCR. The antibiotic resistance profile of the TOP10 *E. coli* containing pTOPO-*MUS* vector was then determined.

Molecular strain typing {#sec2.5}
-----------------------

The three isolates were typed by the pulsed-field gel electrophoresis (PFGE) method as previously described [@bib4]. The DNA was digested with *Sma*I restriction enzyme and the fragments of DNA were separated using a GenePath system (Bio-Rad). The running conditions were 6 V/cm at 14°C for 20 h.

Results {#sec3}
=======

During a previous study that was aiming to detect carbapenemases encoding genes in animals in livestock farms in Lebanon [@bib10], three isolates of *M. odoratimimus* were isolated and were studied separately. These isolates were obtained after culture of animal faeces in MacConkey agar supplemented with ertapenem (1 mg/L) and were identified by MALDI-TOF MS as *M. odoratimimus* (score: 2.439). The results of antibiotic susceptibility testing revealed that the isolates were resistant to almost all antibiotics, including β-lactams, aminoglycosides and colistin but remain susceptible to sulfamethoxazole-trimethroprim, rifampicin and fluoroquinolones ([Table 1](#tbl1){ref-type="table"}). In addition, all the isolates showed resistance to carbapenems with MIC for imipenem at 8 mg/L. The isolates were then analysed via the modified Hodge test, the MALDI-TOF MS Ultraflex assay, the EDTA-disc test and the modified CarbaNP test and they were all positive on the modified Hodge test, EDTA-disc and modified CarbaNP test positive. In addition, the MALDI-TOF MS Ultraflex assay was positive for all of them---suggesting a carbapenemase production, more specifically a metallo-β-lactamase as the EDTA test was positive. Screening for carbapenemase-encoding genes by PCR using carbapenemase gene primers showed a negative result for *bla*~VIM~, *bla*~IMP~, *bla*~NDM-1~, *bla*~KPC~ and all the *bla*~OXA~ variants. However the chromosomal MUS gene was amplified using primers MUS-F/R.

Sequencing of the chromosomal *MUS* gene of the three isolates and nucleotide alignment between the *bla*~MUS-1~ and the new *bla*~MUS~ sequence showed some differences. The *bla*~MUS-2~ differed from *bla*~MUS-1~ due to substitution in nucleotides at positions 69 (A→G), 525 (A→G), 171 (C→T), 177 (C→T), 397 (C→T), 671 (C→T), 179 (T→C), 514 (T→C) and 675 (C→G), resulting in a different protein MUS-2 that differ from MUS-1 protein due to substitution of amino acid at position 60 (Valine→Alanine), 133 (Histidine→Tyrosine) and 224 (Threonine→Isoleucine) ([Fig. 1](#fig1){ref-type="fig"}). The percentage of homology between the two amino acid sequences was 98.78.

The new enzyme variant was designated MUS-2 by the curators of the Lahey database of β-lactamases (<http://www.lahey.org/Studies/webt.asp>) and deposited in GenBank under accession number KP658209.

Cloning of the *Bla*~*MUS-2*~ successfully gave plasmids harbouring this gene; these plasmids were transformed into TOP10 Electrocomp™ *E. coli*. The presence of the insert was verified by PCR. MIC values of β-lactams for the *E. coli* TOP10 strain, which harbours recombinant plasmid pTOPO-*MUS-2,* showed that the bacteria was resistant to amoxicillin and ticarcillin and had a reduced susceptibility to piperacillin, in addition it showed an increased resistance to extended-spectrum cephalosporins and carbapenems by at least four-fold of MIC ([Table 2](#tbl2){ref-type="table"}).

Finally, PFGE analysis showed that the three strains of *M. odoratimimus* were genetically clonal since their PFGE profiles were similar ([Fig. 2](#fig2){ref-type="fig"}).

Discussion {#sec4}
==========

To date, infections caused by *M. odoratimimus* in immunocompromised and immunocompetent hosts had been rarely reported [@bib1; @bib2; @bib4; @bib5; @bib6; @bib7; @bib8]. The fact that this bacterium might cause infection in immunocompetent hosts is a real health problem because it is resistant to β-lactams including carbapenems, aminoglycoside but also to colistin. Biochemical detection of β-lactamases in clinical strains of *Myroides* spp. (formerly *F. odoratum*) was performed in 1985 by Sato et al. [@bib21], but the molecular characteristics of β-lactamase were not reported. We would have to wait until 2002 when Mammeri et al. biochemically and genetically characterized β-lactamases expressed in *M. odoratimimus* and *M. odoratus*[@bib9]. In fact, *M. odoratimimus* species produce chromosomal MUS-1 β-lactamase, which belongs to the subclass B1 of Ambler classification, and their antibiotic resistance patterns show a constant decreased susceptibility to imipenem [@bib9].The β-lactamase produced by the three *M. odoratimimus* isolates in our study shared 98.78% amino acid identity with the known MUS-1 protein. At the present time, each bacterial species of the *Flavobacteriaceae* family that has been investigated for β-lactamase characterization produces a subclass B1 metalloenzyme [@bib9]. Our study confirms a previous study performed on *M. odoratimimus* species; however, here we report a new variant of this enzyme in Lebanon. PFGE analysis showed that these isolates belong to the same clone because they had the same PFGE profile. This confirms that contamination between farms has occurred and precautions should be established to limit the emergence of this clone in livestock farms because that could be a source of human infection.

Taking into consideration the biochemical criteria established by Rasmussen and Bush to classify metallo-β-lactamases [@bib22], MUS-1 and most probably MUS-2 belong to functional subgroup 3a, as their catalytic efficiencies for penicillins are at least 60% of that for imipenem [@bib9]. However, these data are discrepant with those from Rasmussen and Bush [@bib22], who mentioned that a metallo-β-lactamase produced by *F. odoratum* strain belongs to subgroup 3b, which groups true carbapenem-hydrolysing β-lactamases. Regarding this conflict, it is very difficult to estimate the exact role of either MUS-1 or MUS-2 in the intrinsic β-lactam resistance of *M. odoratimimus* because the metalloenzymes expressed in *E. coli* give much lower levels of resistance to β-lactams than those seen in the original producers as seen in the TOP10 *E. coli* after cloning.

Finally, it remains unknown if these bacteria could be a source of such a variety of metalloenzymes. The most serious finding is that animals could be a reservoir for such genes and are a source of new and/or emerging multidrug-resistant bacteria and due to possible links with animals, humans may have high risk factors for colonization/infection with such bacteria.

In conclusion, we report a novel variant of the chromosome-encoded β-lactamase MUS-1 that has been designated MUS-2 from *M. odoratimimus* isolates from livestock animals in Lebanon.
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![Amino acid sequence alignment between the MUS-1 and MUS-2 proteins.](gr1){#fig1}

![Pulsed-field gel electrophoresis of *Sma*I DNA restriction digests of the three *Myroides odoratimimus* isolates.](gr2){#fig2}

###### 

Antimicrobial susceptibility testing of the three *Myroides* isolates

            TIC   PRL   TIM   TPZ   CAZ   FEP   CTX   ETP   MEM   IPM   TOB   AMK   GEN   CIP   ATM   RA   SXT   CT
  --------- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ---- ----- ----
  MO_32     R     R     R     R     R     R     R     R     R     R     R     R     R     I     R     S    S     R
  MO_35a    R     R     R     R     R     R     R     R     R     R     R     R     R     I     R     S    S     R
  MO_104b   R     R     R     R     R     R     R     R     R     R     R     R     R     I     R     S    S     R

MO, *Myroides odoratimimus*; TIC, ticarcillin; PRL, piperacillin; TIM, ticarcillin-clavulanic acid; TPZ, piperacillin-Tazobactam; CAZ, ceftazidime; FEP, cefepime; CTX, cefotaxime; ETP, ertapenem; MEM, meropenem; IPM, imipenem; TOB, tobramycin; AMK, amikacin; GEN, gentamicin; CIP, ciprofloxacin; ATM, aztreonam; RA, rifampicin; SXT, sulfamethoxazole-trimethroprim; CT, colistin; R, resistant; I, intermediate; S, susceptible.

###### 

MICs of β-lactams for *Myroides odoratimimus* 35a, TOP10 *Escherichia coli* and TOP10 *E. coli* pTOPO-*MUS-2*

  Substrate[a](#tbl2fna){ref-type="table-fn"}   MIC (μg/mL)           
  --------------------------------------------- ------------- ------- -------
  Amoxicillin                                   32            128     2
  Amoxicillin-CLA                               32            128     2
  Ticarcillin                                   256           256     2
  Piperacillin                                  128           8       2
  Piperacillin-TZB                              24            8       1
  Cephalotin                                    128           8       2
  Cefoxitin                                     32            4       2
  Moxalactam                                    32            0.064   0.19
  Cefotaxime                                    32            0.094   0.047
  Cefuroxime                                    128           6       1
  Ceftazidime                                   128           0.38    0.064
  Cefepime                                      32            0.064   0.064
  Cefpirone                                     32            0.064   0.064
  Aztreonam                                     64            0.064   0.064
  Imipenem                                      8             0.38    0.064
  Meropenem                                     4             0.38    0.064

CLA, clavulanic acid at 2 μg/mL; TZB, tazobactam at 4 μg/mL.
